SCHEMBL229180

SCHEMBL229180

Cc1cc(F)ccc1C(=O)C1CCN(CCC2CCC(N)CC2)CC1

nearest known ligand 0.48

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.46
DRD2 P14416 2/20 0.46
HTR2C P28335 3/20 0.45
HTR7 P34969 2/20 0.45
HTR6 P50406 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
GRM2 Q14416 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27737568 1.00 HTR2A (0.46) HTR2ADRD2HTR2CHTR7HTR6
SCHEMBL228770 0.89 HTR2A (0.44) HTR2ADRD2HTR2CHTR7HTR6
SCHEMBL228857 0.89 HTR2A (0.47) HTR2ADRD2HTR2CHTR7HTR6
SCHEMBL229932 0.89 HTR2A (0.47) HTR2ADRD2HTR2CHTR7HTR6
SCHEMBL230816 0.87 HSD11B1 (0.49) HTR2ADRD2HTR2CHTR7HTR6
SCHEMBL27758351 0.87 HSD11B1 (0.49) HTR2ADRD2HTR2CHTR7HTR6
SCHEMBL224996 0.84 HTR2C (0.63) HTR2AHTR2CHTR7HTR6SMN1; SMN2
SCHEMBL224995 0.84 HTR2C (0.63) HTR2AHTR2CHTR7HTR6SMN1; SMN2
Hydrochloric Acid SCHEMBL337480 0.83 HTR2C (0.62) HTR2AHTR2CHTR7HTR6SMN1; SMN2
Hydrochloric Acid SCHEMBL337481 0.83 HTR2C (0.62) HTR2AHTR2CHTR7HTR6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415350-B2 Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors HOFFMANN-LA ROCHE INC. (US) 2013-04-09 US disclosed
US-20120004208-A1 BENZOYL-PIPERIDINE DERIVATIVES AS DUAL MODULATORS OF THE 5-HT2A AND D3 RECEPTORS GOBBI LUCA (CH) 2012-01-05 US disclosed
US-8039490-B2 Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors HOFFMANN-LA ROCHE INC. (US) 2011-10-18 US disclosed
EP-1987019-A1 BENZOYL-PIPERIDINE DERIVATIVES AS 5HT2/D3 MODULATORS F.HOFFMANN-LA ROCHE AG (CH) 2008-11-05 EP disclosed
WO-2007093540-A1 BENZOYL-PIPERIDINE DERIVATIVES AS 5HT2/D3 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-23 WO disclosed
US-20070197531-A1 Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004208-A1 BENZOYL-PIPERIDINE DERIVATIVES AS DUAL MODULATORS OF THE 5-HT2A AND D3 RECEPTORS HTR2A, HTR3A, HTR2C HTR2A 1/4885DRD2 16/4885HTR2C 3/4885
US-20070197531-A1 Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors HTR2A, HTR3A, HTR2C HTR2A 1/4885DRD2 16/4885HTR2C 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.